|
Market Cap (5-Jun) $13,719,451 (1,617th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 431,146 |
Shortsold (21-Jul) 380,000 (0.14%) (384th) |
|
52w High $0.098 |
52w Low $0.026 |
P/E - |
EPS -0.02 |
IMC released this announcement to the ASX on 13 January 2022, 9:33. The announcement is marked as price sensitive, and is 2 page(s) in length and 301.66kb in size.
You can view all announcements from IMC and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMC was 0.002% short sold according to ASIC data. It was ranked the 616th most shorted stock on the ASX. It is now ranked as the 384th most shorted stock on the ASX with 0.142% of total shares short sold as of the latest reported data (21 July 2025).
| Other Recent Announcements from IMC | |
|---|---|
| Immuron Chairman Transition | 30 June 2023, 11:03 |
| Letter to Shareholders | 22 June 2023, 8:27 |
| Immuron CEO, Steven Lydeamore presents at LD Micro | 7 June 2023, 8:26 |
| Immuron Receives European Patent on Drug to Treat Diarrhea | 13 January 2022, 9:33 |
| Change in substantial holding | 13 January 2022, 8:26 |
| Immuron awarded A$6.2 million US DoD funding for Travelan | 12 January 2022, 9:58 |
| Change in substantial holding | 6 January 2022, 8:21 |
You must be logged in to post a reply.
Immuron 